Literature DB >> 14748091

Laboratory evolution of cytochrome p450 BM-3 monooxygenase for organic cosolvents.

Tuck Seng Wong1, Frances H Arnold, Ulrich Schwaneberg.   

Abstract

Cytochrome p450 BM-3 (EC 1.14.14.1) catalyzes the hydroxylation and/or epoxidation of a broad range of substrates, including alkanes, alkenes, alcohols, fatty acids, amides, polyaromatic hydrocarbons, and heterocycles. For many of these notoriously water-insoluble compounds, p450 BM-3's K(m) values are in the millimolar range. Polar organic cosolvents are therefore added to increase substrate solubility and achieve high catalytic efficiency. Using p450 BM-3 as a catalyst for these important transformations requires that we improve its ability to tolerate the cosolvents. By directed evolution, we improved the activity of p450 BM-3 in the presence of dimethylsulfoxide (DMSO) and tetrahydrofuran (THF), achieving increases in specific activity up to 10-fold in 2% (v/v) THF and 6-fold in 25% (v/v) DMSO. The engineered p450 BM-3's are also significantly more resistant to acetone, acetonitrile, dimethylformamide, and ethanol as cosolvents in the reaction. Copyright 2004 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14748091     DOI: 10.1002/bit.10896

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  26 in total

Review 1.  Laboratory-directed protein evolution.

Authors:  Ling Yuan; Itzhak Kurek; James English; Robert Keenan
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

2.  Biocatalytic conversion of avermectin to 4''-oxo-avermectin: improvement of cytochrome p450 monooxygenase specificity by directed evolution.

Authors:  Axel Trefzer; Volker Jungmann; István Molnár; Ajit Botejue; Dagmar Buckel; Gerhard Frey; D Steven Hill; Mario Jörg; James M Ligon; Dylan Mason; David Moore; J Paul Pachlatko; Toby H Richardson; Petra Spangenberg; Mark A Wall; Ross Zirkle; Justin T Stege
Journal:  Appl Environ Microbiol       Date:  2007-05-04       Impact factor: 4.792

3.  Enzyme stabilization via computationally guided protein stapling.

Authors:  Eric J Moore; Dmitri Zorine; William A Hansen; Sagar D Khare; Rudi Fasan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205

Review 4.  Engineering cytochrome P450 enzyme systems for biomedical and biotechnological applications.

Authors:  Zhong Li; Yuanyuan Jiang; F Peter Guengerich; Li Ma; Shengying Li; Wei Zhang
Journal:  J Biol Chem       Date:  2019-12-06       Impact factor: 5.157

5.  Rapid and quantitative measurement of metabolic stability without chromatography or mass spectrometry.

Authors:  Matthew J Traylor; Jessica D Ryan; Eric S Arnon; Jonathan S Dordick; Douglas S Clark
Journal:  J Am Chem Soc       Date:  2011-07-27       Impact factor: 15.419

6.  A Continuing Career in Biocatalysis: Frances H. Arnold.

Authors:  Rudi Fasan; S B Jennifer Kan; Huimin Zhao
Journal:  ACS Catal       Date:  2019-09-17       Impact factor: 13.084

7.  Structural evidence: a single charged residue affects substrate binding in cytochrome P450 BM-3.

Authors:  Jaclyn Catalano; Kianoush Sadre-Bazzaz; Gabriele A Amodeo; Liang Tong; Ann McDermott
Journal:  Biochemistry       Date:  2013-09-16       Impact factor: 3.162

8.  Calcium-ion-induced stabilization of the protease from Bacillus cereus WQ9-2 in aqueous hydrophilic solvents: effect of calcium ion binding on the hydration shell and intramolecular interactions.

Authors:  Jiaxing Xu; Yu Zhuang; Bin Wu; Long Su; Bingfang He
Journal:  J Biol Inorg Chem       Date:  2013-01-16       Impact factor: 3.358

Review 9.  Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation.

Authors:  Santosh Kumar
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-02       Impact factor: 4.481

10.  Chemo-enzymatic fluorination of unactivated organic compounds.

Authors:  Andrea Rentmeister; Frances H Arnold; Rudi Fasan
Journal:  Nat Chem Biol       Date:  2008-11-16       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.